Related Experiment Video

Updated: Sep 22, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.9K

[Tuberculous Meningitis in Which Inflammation Cannot Be Adequately Suppressed by Standard Therapy: How to Think and

Tetsuya Abe1, Toshihiro Fukusako

  • 1Department of Neurology, Yamaguchi Prefectural Grand Medical Center.

Brain and Nerve = Shinkei Kenkyu No Shinpo
|May 19, 2022
PubMed

Insights

Tuberculous meningitis is a severe tuberculosis form with high mortality. Early treatment initiation is crucial, even without a definitive diagnosis, and continued management is vital for resistant cases.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Public Health

Background:

  • Tuberculous meningitis (TBM) represents the most severe manifestation of tuberculosis.
  • TBM is associated with critical illness and high mortality rates.
  • Prompt management is essential due to the severity and potential for rapid deterioration.

Purpose of the Study:

  • To underscore the urgency of initiating treatment for suspected tuberculous meningitis.
  • To highlight the challenges posed by treatment-resistant TBM.
  • To emphasize the importance of continued diagnostic and therapeutic efforts in TBM management.

Main Methods:

  • This study is a review of current clinical practices and literature regarding TBM.
  • It synthesizes evidence on diagnostic challenges and treatment strategies.
  • Focuses on the clinical course and outcomes of TBM patients.

Main Results:

  • Tuberculous meningitis requires immediate treatment initiation, often before definitive diagnosis confirmation.
  • Treatment resistance is a significant challenge in managing TBM.
  • Persistent clinical examination and treatment are critical for improving patient outcomes.

Conclusions:

  • Early empiric treatment for TBM is paramount to reduce mortality.
  • Addressing treatment resistance requires ongoing research and clinical vigilance.
  • A sustained approach to diagnosis and treatment is vital for managing this severe condition.

More Related Videos

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

362
Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis06:23

Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis

Published on: May 23, 2021

5.0K

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
251
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
214
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
407
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
335
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
466
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
463